Publications by Year: 2024

2024
Kostaki EG, Roussos S, Kefala AM, Limnaios S, Psichogiou M, Papachristou E, Nikolopoulos G, Flountzi E, Friedman SR, Lagiou P, et al. Molecular epidemiology of HIV among people who inject drugs after the HIV-outbreak in Athens, Greece: Evidence for a 'slow burn' outbreak. Infect Genet Evol. 2024;121:105597.
Roussos S, Pantazis N, Protopapas K, Antoniadou A, Papadopoulos A, Lourida G, Papastamopoulos V, Chini M, Alexakis K, Barbounakis E, et al. Missed opportunities for early HIV diagnosis in Greece: The MORFEAS study, 2019 to 2021. Euro Surveill. 2024;29.
Roussos S, Angelopoulos T, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Chounta A, Ioannidou P, Deutsch M, Manolakopoulos S, et al. High levels of all-cause mortality among people who inject drugs from 2018 to 2022. Int J Drug Policy. 2024;126:104356.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, et al. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions. Lancet Gastroenterol Hepatol [Internet]. 2024. Website
Chun HS, Papatheodoridis GV, Lee M, Lee HA, Kim YH, Kim SH, Oh YS, Park SJ, Kim J, Lee HA, et al. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B. J Hepatol [Internet]. 2024;80:20-30. Website